Shengwen Zang

机构：Io Therapeutics (United States)

发表论文 1 篇 · 总被引 57 次 · h-index 1

代表论文

• Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia (2020 · Hepatology · 被引 55)